Search Results 1661-1670 of 21310 for anti-TNF drugs

1. A Dose Escalation Study of Amivantamab in Participants with Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Any previous treatment with systemic anti cancer immunotherapy, including but not limited to anti-PD-1, anti-PD-L1, and anti-CTLA-4 agents. For Part 1 ...

2. Tiotropium (Inhalation Route) Description and Brand Names - Mayo Clinic

   Tiotropium belongs to the family of medicines known as bronchodilators. Bronchodilators are breathed in through the mouth to help open up the bronchial ...

3. Non-Hodgkin's Lymphoma Clinical Trials - Mayo Clinic Research

   Rituximab, an anti-CD20 chimeric antibody, was approved by the United States Food and Drug Administration in 1998 for the treatment of patients with relapsed ...

4. A Study to Evaluate Fostamatinib Disodium to Treat Warm Antibody Autoimmune Hemolytic Anemia - Mayo Clinic

   ... anti-IgG or anti-IgA. Have failed or not tolerated at least one prior wAIHA treatment regimen, including steroids, rituximab, azathioprine, cyclophosphamide ...

5. Clozapine (Oral Route) Proper Use - Mayo Clinic

   Proper Use. Drug information provided by: Merative, Micromedex®. Take this medicine only as directed by your doctor. Do not take more of it, do not take it ...

6. Analgesic Combination, Acetaminophen/Salicylate (Oral Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

7. Myeloid Cell Interactions Modulate Combination Immunotherapy Outcomes in the Liver Tumor Microenvironment - Mayo Clinic Comprehensive Cancer Center Research

   We have conducted preliminary studies of combination anti-PD-1 and anti-PD-L1 ICI treatment on B16 tumors. Once inoculated, tumors rapidly grew logarithmically ...

8. A Study to Evaluate the Effectiveness and Safety of Pembrolizumab Combined with Bacillus Calmette-Guerin in High-Risk Non-Muscle Invasive Bladder Cancer - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo ... - Has received prior systemic anti-cancer therapy including investigational agents

9. Docetaxel (Intravenous Route) Description and Brand Names - Mayo Clinic

   Docetaxel injection is also used together with cisplatin and fluorouracil as first treatment for advanced squamous cell carcinoma of the head and neck (SCCHN).

10. Arsenic Trioxide (Intravenous Route) Side Effects - Mayo Clinic

    Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...